title: Single-cell RNA-seq of 1.3 million brain cells from E18 mice

city: Pleasanton

first: Grace

state: California

address: 7068 Koll Center Parkway, Suite # 401

institute: 10X Genomics Inc

summary: We have made scRNA-Seq libraries from 1.3 million brain cells from 2 E18 mice, and sequenced each cell to ~18,500 reads/cell.

overall_design: Cortex, hippocampus, and subventricular zone were purchased from BrainBits (C57EHCV). They were from 2 E18 C57BL/6 mice dissected on the same day, shipped overnight on ice, and stored at 4C until being prepared for scRNA-Seq. Brain tissues were dissociated following the Demonstrated Protocol for Mouse Embryonic Neural Tissue (https://support.10xgenomics.com/single-cell/sample-prep/doc/demonstrated-protocol-dissociation-of-mouse-embryonic-neural-tissue-for-single-cell-rna-sequencing). 69 scRNA-Seq libraries were made from first mouse brain 2 days after the dissection. Another 64 scRNA-Seq libraries were made from second mouse brain 6 days after the dissection.


title: RNA-seq of Arabidopsis thaliana seedlings overexpressing the transcription factor TCP14

status: Public on Jan 12 2017

city: Piracicaba

first: Paulo

last: Teixeira

state: SP

address: Av. Pádua Dias, 11

department: Biology

country: Brazil

institute: University of São Paulo (ESALQ/USP)

type: Expression profiling by high throughput sequencing

summary: This study evaluates the transcriptome of transgenic Arabidopsis seedlings expressing the transcription factor TCP14 (AT3G47620) under the UBQ10 promoter.

overall_design: Arabidopsis thaliana seedlings were grown under short day conditions (9h of light at 21°C - 15h of dark at 18°C) for two weeks. Samples were harvested in the beginning of the light period and used for RNA extraction and Illumina sequencing. Lines Col-0 (4 replicates), UBQ10::YFP-TCP14-3 (4 replicates), UBQ10::YFP-TCP14-4 (1 replicate), and coi1-16 (2 replicates) were used in the experiment. Each replicate corresponds to approximately 30 seedlings grown in the same pot.

first: Li

last: Yang

first: Jeff

last: Dangl


title: RNA-seq of Arabidopsis thaliana seedlings with T-DNA insertions in TCP14

summary: This study evaluates the transcriptome of Arabidopsis seedlings with loss-of-function TCP14 alleles

overall_design: Arabidopsis thaliana seedlings were grown under short day conditions (9h of light at 21°C - 15h of dark at 18°C) for two weeks. Samples were harvested in the beginning of the light period and used for RNA extraction and Illumina sequencing. Lines Col-0 (3 replicates), tcp14-6 (3 replicates) and tcp14-7 (3 replicates) were used in the experiment. Each replicate corresponds to approximately 30 seedlings grown in the same pot.


title: RNA-seq of Arabidopsis thaliana seedlings treated with MeJA or BTH

summary: This study evaluates the transcriptome of Arabidopsis thaliana seedlings (Col-0 ecotype) treated with methyl jasmonate (MeJA) or with the salicylic acid analog benzothiadiazole (BTH).

overall_design: Two-week-old Arabidopsis thaliana seedlings (Col-0 ecotype) grown under short day conditions (9h of light at 21°C - 15h of dark at 18°C) were sprayed with 50 μM MeJA (Sigma), 300 μM BTH (Actigard 50WG) or a mock solution (0.02% Silwet, 0.1% ethanol). Samples were harvested 1h, 5h and 8h after spraying and used for RNA extraction and Illumina sequencing. The experiment includes two independent biological replicates per condition. Each replicate corresponds to approximately 30 seedlings grown in the same pot.


title: Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis

status: Public on Jan 13 2017

city: hackensack

first: Benjamin

last: Tycko

state: NJ

address: 40 prospect avenue

department: Epigenetics

country: USA

institute: HUMC

type: Methylation profiling by genome tiling array

summary: This SuperSeries is composed of the SubSeries listed below.

overall_design: Refer to individual Series


title: Genome-wide RNA-seq profiles in mouse ESCs and ESC-derived cells

city: Beijing

first: Runsheng

last: Chen

address: 15 Datun Road, Chaoyang District

department: CAS Key Laboratory of RNA Biology

country: China

institute: Institute of Biophysics, Chinsese Academy of Sciences

type: Non-coding RNA profiling by high throughput sequencing

summary: Investigation of differentially expressed lncRNAs in pluripotent cells and differentiation cells

overall_design: mRNA profiles of mouse ESCs and ESC-derived cells were generated by deep sequencing

first: Buqing

last: Ye

first: Benyu

last: Liu

first: Liuliu

first: Xiaoxiao

last: Zhu

first: Dongdong

last: Zhang

first: Wei

last: Wu

first: Pingping

first: Yanying

last: Wang

first: Shuo

first: Pengyan

last: Xia

first: Ying

last: Du

first: Shu

last: Meng

first: Guangling

last: Huang

first: Jiayi

first: Yong

last: Tian

first: Zusen

last: Fan


title: Infection of Arabidopsis thaliana seedlings with the Pseudomonas syringae strain DC3000 cor- carrying the effector HopBB1

first: Paulo

last: Teixeira

summary: This study evaluates the transcriptome of Arabidopsis thaliana infected with the Pseudomonas syringae strain DC3000 cor- carrying the type three secretion system effector HopBB1

overall_design: Two-week-old Arabidopsis thaliana seedlings (Col-0 ecotype) were sprayed with a mock solution (10 mM MgCl2) or bacteria [Pto DC3000 (EV), Pto DC3000 cor- (EV); Pto DC3000 cor- (HopBB1); Pto DC3000 cor- (HopBB1G126D)] at OD600=0.2 with 10mM MgCl2 and 0.04% Silwet L-77. Samples were harvested 24 hours after infection. This experiment included three biological replicates, each one corresponding to approximately 30 seedlings grown in the same pot.

first: Li

first: Jeff


title: KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors

city: Xiamen

first: Yingjia

last: Shen

state: Fujian

address: A316 Jingquan Building

department: Ecology

institute: Xiamen University

summary: The purpose of this study is to identify expression differences between untreated and Doxycycline treated human malignant peripheral nerve sheathing tumors (MPNST) cell lines. We sequenced mRNA from 6 lentiviral infected MPNST human stable cell lines(STS26T-pLIX405-KANK1 using Illumina Hiseq 2500 sequencing platform. Three control samples are untreated stable cells and three samples are Doxycycline treated (1 ug/ml).

overall_design: mRNA profiles were examed by Illumina Hiseq 2500 platform. Six samples were sequenced with three untreated stable cells and three Doxycycline treated samples.

first: Guangjun


title: ChIP-seq of c-Myc in lung cancer

city: Salt Lake CIty

first: Jason

last: Gertz

state: UT

address: 2000 Circle of Hope

department: Oncological Sciences

institute: University of Utah

type: Genome binding/occupancy profiling by high throughput sequencing

summary: We report genome wide binding profiles of c-Myc in lung cancer cells. We performed ChIP-seq of c-Myc in three cell lines that were derived from a mouse model of lung cancer.  Binding sites were identified by comparing to input controls.

overall_design: ChIP-seq of Myc in three lung cancer lines

first: Trudy

last: Oliver

first: Jay

first: Jeffery

last: Vahrenkamp


title: Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis

city: New Haven

first: Naftali

last: Kaminski

state: CT

address: 300 Cedar St

department: Pulmonary, Critical Care and Sleep Medicine

institute: Yale School of Medicine

summary:
BACKGROUND: Idiopathic Pulmonary Fibrosis (IPF) is a lethal lung disease of unknown etiology. A major limitation in transcriptomic profiling of lung tissue in IPF has been a dependence on snap-frozen fresh tissues (FF). In this project we sought to determine whether RNA-Seq could be used to identify IPF expression profiles from archived Formalin-Fixed Paraffin-Embedded (FFPE) lung fibrotic tissue.
RESULTS: We isolated total RNA from 7 IPF and 5 control FFPE lung tissues (median archived time 6 years) and performed 50 bp paired-end sequencing on Illumina 2000 HiSeq. TopHat2 was used to map sequencing reads to the human genome. On average ~62 million reads (53.4% of ~116 million reads) were mapped per sample. Cufflinks calculated FPKM values (Fragments per Kilobase of exon per Million) and identified differentially expressed genes between the IPF and control samples. Here we show that RNA-Seq data obtained from FFPE lung tissues is comparable to microarray data obtained from IPF fresh frozen tissues. Pathway enrichment and network analysis confirmed numerous IPF relevant genes and pathways.
CONCLUSION: Our results demonstrate that transcriptomic analysis of RNA obtained from archived FFPE lung tissues is feasible. Therefore FFPE IPF lungs can be used as a valid and reliable source for transcriptomic profiling in IPF

overall_design: RNA-Seq was performed on mRNA isolated from 6 IPF and 5 control lung FFPE tissues by using Illumina HiSeq 2000

first: Milica

last: Vukmirovic

first: Jose

middle: D

last: Herazo-Maya

first: Branko

last: Stefanovic


title: Next Generation Sequencing (NGS) of zebrafish larvae microRNA expression profilling by 2,2',4,4'-tetrabromodiphenyl ether (BDE47) treatment

city: Shanghai

first: Ting

last: Xu

address: No. 1239 Road Siping

institute: Tongji University

summary:
Purpose: We report the application of NGS for the impacts of BDE47 exposure on the miRNA expression profiling of zebrafish larvae.
Methods: miRNA profiles of 6-day-old BDE47-treated and control zebrafish larvae were generated by deep sequencing using Illumina Hisq 2000 platform. The sequence reads that passed quality filters were analyzed at the transcript isoform level with TopHat followed by Cufflinks.
Results: Compared BDE47 treatments with solvent control, a dozen of validated zebrafish miRNAs, including dre-miR-142a-3p, dre-miR-142b-5p, dre-miR-144-3p, dre-miR-146a, dre-miR-190a, dre-miR-219-5p, dre-miR-301b-3p, dre-miR-459-5p, rno-miR-33-5p, dre-miR-735-3p, and dre-miR-735-5p, significantly changed their expressions.
Conclusions: This study provides a framework for the application of high-throughput sequencing towards characterization of the impacts of BDE47 on whole zebrafish larval miRNA expression profiling.

overall_design: Examination of zebrafish larvae miRNA expression profilings with blank, vehicle and 2 different concentrations of BDE47 treatments.

first: Jing

last: Zhao


title: Identification of the RNA Pyrophosphohydrolase RppH of Helicobacter pylori and Global Analysis of Its RNA Targets

city: Würzburg

first: Thorsten

last: Bischler

address: Josef-Schneider-Straße 2 / D15

department: Core Unit SysMed

country: Germany

institute: University of Wuerzburg

summary: In this study targets of the RNA pyrophosphohydrolase RppH in H. pylori 26695 (HP1228) were identified.

overall_design: To investigate the global role of HpRppH (HP1228) in converting 5’ triphosphates to monophosphates in H. pylori, we used a variant of differential RNA-seq (dRNA-seq) to compare the transcriptome of isogenic strains containing or lacking the rppH gene. For this purpose, we constructed two derivatives of the wild-type H. pylori strain 26695: an rppH deletion mutant (ΔrppH) and an rppH complementation strain (CrppH) bearing an ectopic copy of the rppH gene. The ΔrppH strain was generated by replacing the rppH gene of wild-type cells (WT) with a kanamycin-resistance cassette. The CrppH strain was then constructed by complementing this deletion with an ectopic copy of the H. pylori rppH gene under the control of its own promoter, which was introduced at an unrelated locus (rdxA) previously used as a site for integrating genes into the H. pylori chromosome. These isogenic H. pylori strains were grown to log phase, and total RNA isolated from each was used to generate three libraries specific for transcripts bearing (1) a 5'-triphosphate, (2) a 5'-monophosphate, or (3) either a 5'-triphosphate or a 5'-monophosphate. This was accomplished by differential treatment of cellular RNA with Terminator 5‘-phosphate-dependent exonuclease (TEX) and Tobacco Acid Pyrophosphatase (TAP). The 5’ exonuclease activity of TEX digests 5‘-monophosphorylated RNAs but leaves triphosphorylated transcripts intact. Subsequent treatment of the latter set of transcripts with TAP generates monophosphorylated 5’ ends to which an RNA oligonucleotide can be ligated, thereby enabling cDNA synthesis.  By contrast, treatment with TAP alone enables cDNA synthesis from both triphosphorylated and monophosphorylated RNAs, whereas treatment with neither enzyme allows cDNA synthesis only from cellular RNAs that are already monophosphorylated.  Therefore, to identify RNAs in each category, we generated cDNA libraries specific for transcripts with a 5'-triphosphate (+TEX/+TAP), a 5'-monophosphate (-TEX/-TAP), or both (-TEX/+TAP) from all three strains (Figure 5A) and subjected them to Illumina sequencing.

first: Ping-kun

last: Hsieh

first: Marcus

last: Resch

first: Quansheng

last: Liu

first: Hock

middle: S

last: Tan

first: Patricia

middle: L

last: Foley

first: Anika

last: Hartleib

first: Cynthia

middle: M

last: Sharma

first: Joel

middle: G

last: Belasco


title: Epidermis-specific ribosome profiling to describe the translational landscape of SOX2

city: New York

first: Ataman

last: Sendoel

address: York Avenue

institute: Rockefeller University

summary: SOX2 signalling is required SCC initiation and maintenance. Ribosome profiling was used to describe the translational landscape of WT and SOX2 overexpressing P4 epidermis.

overall_design: Mouse P4 WT and SOX2 epidermis was isolated for ribosome profiling and RNAseq. Furthermore, cultured WT, SOX2 and HRASG12V; TGFBR-2 KO keratinocytes were used for ribosome profiling.

first: Elaine

last: Fuchs


title: Vitamin D/Vitamin D Receptor (VDR) Axis Regulates LMNA gene expression [RNA-Seq]

city: St Louis

first: Susana

last: Gonzalo

state: MO

address: 1100 S Grand Blvd

department: Biochemistry and Molecular Biology

institute: Saint Louis University

summary: RNA expression was measured using RNAseq

overall_design: RNA levels of normal human primary fibroblasts treated with active vitamin D (1,25D) for 24 hours were compared to RNA levels of vehicle-treated cells as control

first: Dale

last: Dorsett

first: Ray

last: Kreienkamp


title: MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.

city: Oxford

first: Thomas

last: Milne

address: John Radcliffe Hospital

department: Molecular Haematology Unit

country: United Kingdom

institute: Weatherall Institute of Molecular Medicine

summary: Understanding the underlying molecular mechanisms of defined cancers is crucial for effective personalized therapies. Translocations of the Mixed Lineage Leukemia (MLL) gene produce fusion proteins such as MLL-AF4 that disrupt epigenetic pathways and cause poor prognosis leukemias. Here we find that MLL-AF4 occupies a subset of unmethylated CG-enriched genes in combination with its cofactors Menin/LEDGF and ENL. MLL-AF4 mainly displays a punctate binding pattern near gene promoters, but we also observe a second less common pattern where MLL-AF4 spreads into the gene body and is associated with increased transcription and increased histone H3 lysine 79 methylation (H3K79me2/3). Compared to other H3K79me2/3 marked genes, MLL-AF4 spreading genes are more sensitive to inhibitors of the H3K79 methyltransferase DOT1L. This sensitivity mediates synergistic interactions with additional targeted drug treatments. Therefore, epigenetic spreading and enhanced susceptibility to epidrugs provides a potential new Achilles heel for guiding combination therapies in humans.

overall_design: Examination of gene expression, histone marks and multiple chromatin proteins in MLL leukemia cell lines and patient samples

middle: A

first: Jon

last: Kerry


title: Mapping heterogeneity in a patient-derived melanoma culture by single-cell RNA-seq

city: Leipzig

first: Edith

last: Willscher

address: Haertelstraße 16-18

institute: IZBI

summary: Recent technological advances in single-cell genomics make it possible to analyze cellular heterogeneity of tumor samples. Here, we applied single-cell RNA-seq to measure the transcriptomes of 307 single cells cultured from three biopsies of three different patients with a BRAF/NRAS wild type, BRAF mutant/NRAS wild type and BRAF wild type/NRAS mutant melanoma metastasis, respectively. Analysis based on self-organizing maps identified sub-populations defined by multiple gene expression modules involved in proliferation, oxidative phosphorylation, pigmentation and cellular stroma. Gene expression modules had prognostic relevance when compared with gene expression data from published melanoma samples and patient survival data. We surveyed kinome expression patterns across sub-populations of the BRAF/NRAS wild type sample and found that CDK4 and CDK2 were consistently highly expressed in the majority of cells, suggesting that these kinases might be involved in melanoma progression. Treatment of cells with the CDK4 inhibitor palbociclib restricted cell proliferation to a similar, and in some cases greater, extent than MAPK inhibitors. Finally, we identified a low abundant sub-population in this sample that highly expressed a module containing ABC transporter ABCB5, surface markers CD271 and CD133, and multiple aldehyde dehydrogenases (ALDHs), as markers for melanoma stem or initiating cells. Patient-derived cultures of the BRAF mutant/NRAS wild type and BRAF wild type/NRAS mutant metastases showed more homogeneous single-cell gene expression patterns with gene expression modules for proliferation and ABC transporters. Taken together, our results describe an intertumor and intratumor heterogeneity in melanoma short-term cultures which might be relevant for patient survival, and suggest promising targets for new treatment approaches in melanoma therapy.

overall_design: RNA-seq of 307 single cells cultured from three biopsies of three different patients with a BRAF/NRAS wild type, BRAF mutant/NRAS wild type and BRAF wild type/NRAS mutant melanoma metastasis, respectively.

first: Tobias

last: Gerber

first: Henry

last: Loeffler-Wirth

first: Lydia

last: Hopp

first: Dirk

last: Schadendorf

first: Manfred

last: Schartl

first: Ulf

last: Anderegg

first: Gray

last: Camp

first: Barbara

last: Treutlein

first: Hans

last: Binder

last: Kunz


title: RNA binds to a CBP regulatory motif to stimulate histone acetylation and transcription

city: Philadelphia

first: Daniel

last: Bose

state: PA

address: 3400 Civic Center Blvd., 9th floor

department: Cell and Developmental Biology

institute: University of Pennsylvania

summary: CBP/p300 are transcription co-activators whose binding is a signature of enhancers, cis-regulatory elements that control patterns of gene expression in multicellular organisms. Active enhancers produce bi-directional enhancer RNAs (eRNAs) and display CBP/p300 dependent histone acetylation. Here, we demonstrate that CBP binds directly to RNAs in vivo and in vitro. RNAs bound to CBP in vivo include a large number of eRNAs. Using steady-state histone acetyltransferase (HAT) assays we show that an RNA binding region in the HAT domain of CBP—a regulatory motif unique to CBP/p300—allows RNA to stimulate CBP’s HAT activity. At enhancers where CBP interacts with eRNAs, stimulation manifests in RNA-dependent changes in the histone acetylation mediated by CBP, such as H3K27ac, and by corresponding changes in gene expression. By interacting directly with CBP, eRNAs contribute to the unique chromatin structure at active enhancers, which in turn is required for regulation of target genes.

overall_design: MEFs were treated with 4-thiouridine for 16h, irradiated with 365nm UV and CBP immunopreciptated. RNA species cross-linked to CBP were purified and sequenced. The series contains 2 biological replicates for CBP PAR-CLIP seq, and negative controls for background PAR-CLIP binding: nuclear flag-tagged GFP (nGFP) and the DNA binding domain of yeast protein Gal4p (Gal4-DBD) (two replicates each)

first: Greg

last: Donahue

first: Shelley

last: Berger


title: The potential functions of FOXL2 in different phases of chicken granulosa cells by RNA-seq

city: Wuhan

first: Jing

last: Wang

state: Hubei

address: NO.1 Shizishan street, Hongshan district

institute: Huazhong Agricultural University

summary: RNA-seq were performed to study the altered transcriptions by overexpression of FOXL2 in pre-hierarchical (SGCs) and pre-ovulatory granulosa cells (BGCs)

overall_design: Examination of mRNA levels in two kind of granulosa cells transfected by FOXL2 overexpression or control plasmid,respectively

first: Yanzhang

last: Gong


title: RNA-seq of transgenic Arabidopsis thaliana seedlings expressing the Pseudomonas syringae effector HopBB1

first: Paulo

last: Teixeira

summary: This study evaluates the transcriptome of transgenic Arabidopsis seedlings expressing the effector HopBB1 from the bacteria Pseudomonas syringae

overall_design: Arabidopsis thaliana seedlings were grown under short day conditions (9h of light at 21°C - 15h of dark at 18°C) for two weeks. Samples were harvested in the beginning of the light period and used for RNA extraction and Illumina sequencing. Lines Col-0 (3 replicates) and 35S::HopBB1-10 (3 replicates) were used in the experiment. Each replicate corresponds to approximately 30 seedlings grown in the same pot.

first: Li

last: Yang

first: Jeff

last: Dangl


title: Negative feedback enables oncogenic signaling in pre-B cells and represents a therapeutic target in acute lymphoblastic leukemia

city: San Francisco

first: Huimin

last: Geng

state: CA

address: 513 Parnassus Ave., MSB HSW 1201

department: Department of Laboratory Medicine

institute: UCSF

type: Genome variation profiling by high throughput sequencing

summary: Targeted therapy of cancer typically focuses on the development of agents that will inactivate a transforming oncogene. In this study, we tested the concept that besides the oncogene itself, factors that enable permissiveness of a normal cell to oncogenic signaling represent a novel class of therapeutic targets. This hypothesis was based on our finding that acute activation of oncogenes in normal pre-B cells typically results in immediate cell death, unless pre-B cells were capable of adapting quickly enough to a high level of signaling output in Erk and Stat5 pathways. Surviving pre-B cell clones achieved permissiveness to oncogenic signaling by strong upregulation of negative feedback regulators of Erk (DUSP6, SPRY2, ETV5) and Stat5 (CISH, SOCS2, SOCS3) signaling. Genetic deletion of the sprouty family Ras inhibitor Spry2, the Erk phosphatase Dusp6 or Etv5, a transcriptional activator of SPRY2/DUSP6, decreased robustness of negative feedback control and compromised oncogenic transformation. Likewise, ablation of the suppressors of cytokine signaling (SOCS) family molecules Cish, Socs2 and Socs3 reversed permissiveness of pre-B cells to oncogenic signaling. Searching for factors that limit permissiveness of normal pre-B cells to oncogene signaling, we identified the lymphoid transcription factor IKZF1, which functions as a critical tumor suppressor in pre-B  ALL. IKZF1 binds directly to and transcriptionally represses DUSP6, SPRY2, ETV5, CISH, SOCS2, and SOCS3 promoters, hence lowering the threshold of maximum allowable oncogene signaling strength. Interstingly, a small molecule inhibitor of DUSP6 acutely subverted negative feedback regulation and selectively induced cell death in pre-B ALL cells. In addition, small molecule inhibition of DUSP6 was sufficient to overcome conventional mechanisms of drug-resistance in pre-B ALL and had strong selective activity on drug-resistant patient-derived pre-B ALL cells that were injected into NOD/SCID transplant recipient mice. These findings identify permissive negative feedback control of oncogenic signaling as a previously unrecognized vulnerability of pre-B ALL cells and a new class of potential therapeutic targets.

overall_design: ExomCapture sequencing in a pair of pre-B acute lymphoblastic leukemia samples at diagnosis (LAX7) and at relapse (LAX7R).

first: Markus

last: Muschen


title: Genome-wide small RNAs analysis of simian virus 40 infected cells

status: Public on Jan 11 2017

city: Kunming

first: Jiandong

last: Shi

state: Yunnan

address: 935# Jiaoling Road

department: Department of Vaccine Research

institute: Institute of Medical Biology

summary: The goal of this study was to compare small RNA profiles (sRNA-seq) of simian virus 40 infection and mock infected Vero cells at 72 hours post infection.

overall_design: Small RNA profiles of  simian virus 40 infection and mock infected Vero cells at 72 hours post infection were generated by deep sequencing, in triplicate, using Illumina Hiseq 2500 platform.

first: Yunzhang

last: Hu


title: Sub-kilobase resolution Kc167 cell Hi-C

city: Houston

first: Kyle

last: Eagen

state: TX

address: 1 Baylor Plaza

department: Department of Molecular and Cellular Biology

institute: Baylor College of Medicine

summary: The locations of chromatin loops in Drosophila were determined by Hi-C (chemical cross-linking, restriction digestion, ligation, and high-throughput DNA sequencing).  Whereas most loop boundaries or “anchors” are associated with CTFC protein in mammals, loop anchors in Drosophila were found most often in association with the polycomb group (PcG) protein Polycomb (Pc), a subunit of Polycomb Repressive Complex 1 (PRC1).  Loops were frequently located within domains of PcG-repressed chromatin.  Promoters located at PRC1 loop anchors regulate some of the most important developmental genes and are less likely to be expressed than those not at PRC1 loop anchors.  Although DNA looping has most commonly been associated with enhancer-promoter communication, our results indicate that loops are also associated with gene repression.

overall_design: Hi-C experiments where ligation is performed on beads (tethered) on embryonic Kc167 Drosophila cultured cells from two independent biological replicates.

middle: P

first: Roger

last: Kornberg


title: Global transcriptome changes after nitrogen replenishment in S288c yeast strain

city: Montpellier

first: Bruno

last: Blondin

address: 2 place Pierre Viala

country: France

institute: INRA

summary: The study on the effect of nitrogen replenishment on the gene expression showed that 390 genes were significantly upregulated (with a logFC ranging from 4.5 to 0.8), among which those related to RNA binding, ribosome binding, structural constituent of ribosome, transferase activity and transcription. 833 genes were significantly down-regulated (with a logFC ranging from -0.8 to -5.2) including those related to stress response, amino-acid catabolism process, protein catabolic process (ubiquitin-dependent and vacuolar protein degradation). But the most interesting and unexpected changes were those related to the down-regulation of the glycolytic transcripts. In fact, we observed a rapid down-regulation of many glycolytic mRNA (25/34) 30 min after nitrogen repletion. These data were surprising as expression of the glycolytic genes are generally considered as stable and sometimes they are even used as housekeeping control genes. In addition, the decoupling of the glycolytic gene expression from the expression of RP genes, ribosomal genes or those related to protein synthesis is unique to the present dataset as in most other data expression of these groups are tightly correlated when nutrients are available. This prompts us to examine in some details the factors which led to the control of the glycolytic mRNA instability in conditions of nitrogen replenishment.

overall_design: Analysis used RNA collected at 30 min of the beginning of the alcoholic fermentation of S288C with NH4 addition and S288C with H2O addition (control). Experiments made in duplicates - dye-swap design

first: Catherine

last: Tesnière

first: Martine

last: Pradal

first: Chloé

last: Bessière

first: Isabelle

last: Sanchez

first: Frédéric

last: Bigey


title: Global transcriptome changes after nitrogen replenishment following a rapamycin treatment in S288c yeast strain

summary: The study on the effect of nitrogen replenishment on the gene expression following a rapamycin treatment showed that the down-regulation of the glycolytic transcripts was generally suppressed after this treatment. This indicated that the TOR signaling pathway likely controls the expression of the glycolytic gene under these conditions.

overall_design: Analysis used RNA collected at 30 min of the beginning of the alcoholic fermentation of S288C with NH4 addition and S288C with H2O addition (control) following supplementation with rapamycin (50 mM, addition 60 min before nitrogen or H2O addition). Experiments made in duplicates - dye-swap design


title: High fat diet-induced changes of mouse hepatic transcription and enhancer activity can be reversed by subsequent weight loss.

city: Bethesda

first: Songjoon

last: Baek

state: MD

address: 41 Library Drive

department: CCR

institute: NCI / NIH

summary: In this setup we have used RNA-seq, DHS-seq, and H3K27ac ChIP-seq to identify changes in transcription, chromatin landscape and enhancer activity in livers of mice fed a high fat diet (HFD) and mice returned from HFD to Chow.

overall_design: Global gene expression analysis, DHS-seq and H3K27ac ChIP-seq in livers of 7 week old mice fed chow or  HFD. Furthermore, we have performed global gene expression analysis and H3K27ac ChIP-seq in 12 week old mice initially fed HFD then returned to chow or continued chow diet.

first: Majken

last: Siersbæk

first: Lyuba

last: Varticovski

first: Shutong

first: Ronni

last: Nielsen

first: Susanne

last: Mandrup

first: Gordon

last: Hager

first: Jay

middle: H

last: Chung

first: Lars

last: Grøntved


title: Infection of Arabidopsis thaliana seedlings (Col-0, UBQ10::YFP-TCP14-4, tcp14-6 and coi1-16) with the Pseudomonas syringae strain DC3000 cor-

city: Piracicaba

first: Paulo

last: Teixeira

address: Av. Pádua Dias, 11

institute: University of São Paulo (ESALQ/USP)

summary: This study evaluates the transcriptome of four genotypes of Arabidopsis thaliana infected at the seedling stage with the Pseudomonas syringae strain DC3000 cor-.

overall_design: Arabidopsis thaliana seedlings were grown under short day conditions (9h of light at 21°C - 15h of dark at 18°C) for two weeks. Plants were sprayed with a suspension of the Pseudomonas syringae strain DC3000 cor- and harvested after 24h. A mock treatment was also included. Lines Col-0 (3 replicates), UBQ10::YFP-TCP14-4 (3 replicates), tcp14-6 (3 replicates) and coi1-16 (3 replicates) were used in the experiment. Each replicate corresponds to approximately 30 seedlings grown in the same pot.

first: Li

last: Yang

first: Jeff

last: Dangl


title: RNA-Seq of STAR-PROM Barcodes

city: Geneva

first: Pauline

last: Gosselin

address: Science II, 30 quai Ernest-Ansermet

department: Molecular Biology

country: Switzerland

institute: University of Geneva

summary: We report the application of a massively parallel STAR-PROM assay based on the RNA-seq of 3000+ luciferase barcodes

overall_design: U2OS cells are transfected with luciferase library, treated with different drugs, and RNA is collected at different time points. Barcodes are amplified by RT-PCR and sequenced.

first: Gianpaolo

last: Rando


title: Deficiency of microRNA miR-34a in pluripotent stem cells expands cell fate potential

city: Padova

first: Davide

last: Risso

address: Via C. Battisti, 241

country: Italy

institute: University of Padova

summary: Mouse embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) exhibit a pluripotent developmental potential, contributing to all embryonic cell types, though rarely to extra-embryonic lineages. Unexpectedly, rare, totipotent-like stem cells have been identified in cultured ESC populations, suggesting the existence of a discrete molecular pathway that regulates the transition between totipotency and pluripotency in vitro. Here, we identify a single miRNA, miR-34a, whose deficiency in mouse pluripotent stem cells expands cell fate potential, giving rise to both embryonic and extra-embryonic lineages in vitro and in vivo. The expression profiles of the totipotent-like miR-34a-knockout murine pluripotent stem cells are characterized by a strong induction of MERVL endogenous retroviruses, a key molecular hallmark shared with totipotent mouse 2-cell blastomeres and totipotent-like mouse ESCs. In all three cell types, a subset of MERVL elements promotes the expression of specific isoforms of the proximal protein-coding genes. We demonstrate that miR-34a represses MERVL expression through transcriptional regulation, at least in part, by directly targeting the transcription factor GATA-binding protein 2 (Gata2). Since MERVL activation correlated precisely with the totipotent-like state, we hypothesized that the miR-34a/Gata2 pathway that regulates MERVL expression in ESCs/iPSCs also regulates the acquisition of totipotency in culture. Consistent with this hypothesis, gata2 knock-down in miR-34a-knockout mouse pluripotent stem cells not only reduced MERVL expression, but also abolished the expanded cell fate potential of these cells both in vitro and in vivo. Taken together, our findings not only provide key insights into the functional importance of miR-34a in restricting the totipotent cell fate potential of pluripotent stem cells, but also elucidate the underlying molecular basis by which miR-34a regulates the developmental potentials of ESCs/iPSCs.

overall_design: Wildtype and miR-34a-deficient iPSCs, three biological replicates per group

first: Yong

middle: J

last: Choi

first: Chao-Po

last: Lin

first: Sean

last: Chen

first: Meng

last: Tan

first: Jin

middle: B

last: Li

first: Yalei

last: Wu

first: Caifu

first: Zhenyu

last: Xuan

first: Todd

last: Macfarlan

first: Weiqun

last: Peng

first: Sang

middle: Y

last: Kim

first: Terence

last: Speed

first: Lin

last: He


title: Comparative mRNA and sRNA transcriptome analysis of TCV-infected wildtype and dcl1-9 mutant Arabidopsis thaliana

city: Singapore

first: Chao

address: 21 Lower Kent Ridge Road

department: Department of Biological Sciences

country: Singapore

institute: National University of Singapore

summary: This SuperSeries is composed of the SubSeries listed below.

overall_design: Refer to individual Series


title: Comparative sRNA-Seq analysis of TCV-infected wildtype and dcl1-9 mutant Arabidopsis thaliana

summary: Belonging to the Carmovirus family, Turnip crinkle virus (TCV) is a positive-strand RNA virus that can infect Arabidopsis. Most Arabidopsis ecotypes are highly susceptible to TCV, except for the TCV resistant line Di-17 derived from ecotype Dijon. Previous studies showed that many of the stress related genes have changed significantly after TCV infection. Besides the virus-triggered genes, small RNAs also play critical roles in plant defense by triggering either transcriptional and/or post-transcriptional gene silencing. In this study, TCV-infected wildtype Arabidopsis thaliana and dcl1-9 mutant plants were subjected to transcriptome and small RNA analysis to investigate the role of DCL1 in virus defense network.

overall_design: 4 week old Arabidopsis thaliana ecotype Col-0 and dcl1-9 homozygous plants were inoculated by TCV. Leaves were collected at 7 dpi for RNA and sRNA extraction.

first: Sek

last: Wang


title: Comparative transcriptome analysis of TCV-infected wildtype and dcl1-9 mutant Arabidopsis thaliana


title: Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq)

city: Iowa City

first: David

last: Price

state: IA

address: 500 Newton Road

department: Biochemistry

institute: University of Iowa

summary: We screened for small molecules that reactivated latent HIV-1 and identified benzotriazoles as latency-reducing agents. Here, we characterize the effects of HODHBt on gene expression in cultured T cells from three donors by polyA RNA-Seq and on STAT5A occupancy of the HIV-1 LTR promoter by ChIP-Seq. These and other results demonstrate that benzotriazoles block SUMOylation of phosphorylated STAT5, prolonging its transcriptional activity.

overall_design: 1 micogram of total RNA from 4.6, 8.3, or 13 million cells (3 donors) per treatment

first: Kyle

last: Nilson

first: Alberto

last: Bosque

first: Amanda

last: Macedo

first: Adam

last: Spivak

first: Nancie

last: Archin

first: Ryan

last: Van Wagoner

first: Laura

last: Martins

first: Camille

last: Novis

first: Matthew

last: Szaniawski

first: Chris

last: Ireland

last: Margolis

first: Vicente

last: Planelles


title: Id2 controls specification of Lgr5+ intestinal stem cell progenitors during gut development

city: Mainz

first: Sergi

last: Sayols

address: Ackermannweg 4

institute: Institute of Molecular Biology, Mainz

summary: To follow the changes in the transcriptional programs accompanying the specification of the adult ISCs we sequenced whole transcriptomes of embryonic intestinal epithelium progenitors (at E11.5 and E12.5) and adult ISCs. EpCAM positive embryonic gut epithelium was isolated from dissected small intestines using fluorescence activated cell sorting (FACS). Adult ISCs were purified on the basis of GFP fluorescence from crypts of Lgr5GFP-Cre-ERT mice (Barker et al. 2007) Double positive adlut ISCs were isolated by FACS based on GFP and tdTomato fluorescence.

overall_design: Intestinal epithelial cells from two embryonic stages (E11.5 and E13.5), mesenchymal (E11.5) and adult Lgr5+ ISCs were used. For embryonic stages biological triplicates were analysed. For the adult ISCs either 4 biological replicates ot duplicates were analysed.

first: Natalia

last: Soshnikova


title: Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (ChIP-Seq)

overall_design: 1.2 million HIV-infected primary T cells per treatment with matching 1% inputs


title: Genome-wide maps of GATA1, TAL1, and H3K27ac occupancy in erythroid precursors

status: Public on Jan 10 2017

city: Boston

first: Daniel

middle: E

last: Bauer

state: MA

address: 1 Blackfan Circle

department: Medicine, Hematology-Oncology

institute: Boston Children's Hospital

summary: We report the occupancy of GATA1 and TAL1, two erythroid transcription factors, and H3K27ac histone modification in human erythroid precursors.

overall_design: Examination of occupancy of two transcription factors and one histone mark by ChIP-seq in erythroid precursors

first: Stuart

last: Orkin


title: Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation

last: Price


title: Genome-wide maps of chromatin binding of FOXD3

city: shanghai

first: wang

last: yujie

state: Shanghai

address: Chi Feng road No:65

institute: Shanghai JiaYin Biological technology co., LTD

summary: The tumor-initiating cells (TIC) are cell population that can initiate tumor, mediate drug resistance, and give rise to metastasis. FOXD3 is a forkhead box (Fox) transcription factor family that regulates the pluripotency of embryonic stem cell and tumorigenicity. However, it is unclear whether FOXD3 play any role in TIC and tumor metastasis. Here, we report that FOXD3 is down-regulated in tumor initiating cells and negatively correlated with higher histologic grades and positive lymph node metastasis. FOXD3 repress TIC expansion, cell migration, drug resistance and osteogenesis in vitro and in vivo. Mechanically, we found that FOXD3 repress a cohort of genes including SET and WDR5 and to regulate several TIC related signaling pathway. Moreover, SET and WDR5 was positively correlated with the CSC abundance and tumor progression. Besides, patients with high expression of SET and WDR5 presented a poorer overall survival. Collectively, our work defined that FOXD3-WDR5-SET axis that repress TIC accumulation and lung cancer progression.

overall_design: FOXD3 chromatin binding sites in A549 cells were generated by…….

first: Jianru

last: Xiao

first: Wei

last: Xu


title: ChIP-seq from A549 (ENCSR991VVW)

city: Stanford

first: ENCODE

last: DCC

address: 300 Pasteur Dr

institute: ENCODE DCC

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Ralstonia solanacearum strain GMI1000: Methylation profile

city: Castanet-Tolosan

first: Ludovic

last: Legrand

address: 24 Chemin de Borde Rouge

institute: INRA/CNRS

type: Methylation profiling by high throughput sequencing

summary: The aim of the project is to decipher the role of DNA methylation in the plant pathogenic bacteria Ralstonia solanacearum during host adaptation. As a first step, we present here the DNA methylation profile of the GMI1000 reference strain.

overall_design: Ralstonia solanacearum GMI1000 methylome

first: Céline

last: Vandecasteele

first: Alice

last: Guidot


title: Genome-wide analysis of PER2  on BMAL1 DNA binding and transcription

city: Taichung

first: Yi-Ying

last: Chiou

address: No.145, Xingda Rd., South Dist.

department: Graduate Institute of Biochemistry

country: Taiwan

institute: National Chung Hsing University

summary: We use PER2-inducible system to analyse BMAL1 chromatin binding by ChIPseq and expression profile by mRNA-Seq. PER2 decrease BMAL1 chromatin bindging but the effect on transcrtipion is gene-specific.

overall_design: Comapration of BMAL1 ChIP-Seq and mRNA-seq between cells with PER2 and without PER2 induction

first: Yanyan

last: Yang


title: ChIP-seq from A549 (ENCSR991RJM)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Transcriptome reponse of Phaeodactylum tricornutum to grazing effect

city: Tianjin

first: Si

last: Li

address: Guangrong Dao 8

institute: Hebei University of Technology

summary: RNA-sequencing was used to evaluate the transcriptomic response to grazing stress for P. tricornutum strain CCAP 1055/1.

overall_design: The mRNA of 9L cultures of strain CCAP 1055/1 under three pairs of control and graz-ing treatments (three pairs of 1 vs 1 replicate) were extracted and submitted to Illumina HiSeq 2500 sequencing platform for paired-end sequencing.

first: Stefanie

last: Ismar


title: In vivo RNA binding sites of the yeast ribosome biogenesis factor Utp23

city: Newcastle upon Tyne

first: Claudia

last: Schneider

address: Framlington Place

institute: Newcastle University

summary:
Purpose: Pre-ribosomal RNA is cleaved at defined sites to release the mature ribosomal RNAs, but the functions of many ribosome biogenesis factors involved in 18S rRNA release are not known. We apply an in vivo cross-linking technique coupled with deep sequencing (CRAC) that captures transcriptome-wide interactions between the yeast PIN domain protein Utp23 and its targets in a living cell.
Methods: We apply CRAC to an HTP-tagged Utp23 protein (HTP: His6 - TEV cleavage site - two copies of the z-domain of Protein A) in budding yeast.  At least two independent experiments were performed and analysed separately. A non-tagged yeast strain was also used as a negative control.
Results: We found that yeast Utp23 UV-crosslinked in vivo to the snR30 snoRNA and to the eukaryotic-specific expansion segment 6 (ES6) in the 18S rRNA.
Conclusion: According to our crosslinking data, Utp23 is perfectly positioned to coordinate release of the snR30 snoRNA from the 18S ES6 region.

overall_design: Examination of targets for RNA-binding ribosome biogenesis factors in yeast cells.

first: Graeme

middle: R

last: Wells

first: Franziska

last: Weichmann

first: Katherine

last: Sloan

first: David

last: Colvin

first: Nicholas

last: Watkins


title: ChIP-seq from A549 (ENCSR814UWE)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR793HZD)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR783THJ)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR871NPV)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR876UZD)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Hi-C from A549 (ENCSR757IVO)

summary:
Hi-C on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR748SVE)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR761RDU)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR664ZHF)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR851SOK)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR701MJQ)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR666BEY)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Hi-C from A549 (ENCSR662QKG)

summary:
Hi-C on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR612GKD)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR565ZHQ)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR560DEL)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR553UWG)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR523BPZ)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR504LBE)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR490YTY)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR426BPV)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR489DIG)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR432AXE)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Hi-C from A549 (ENCSR499RVD)

summary:
Hi-C on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR708DGM)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR431LRW)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR656VWZ)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR384KPP)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR382EJS)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR332WDQ)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR336VBV)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR366VPA)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR328BXP)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR414CQB)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR216DMN)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR226UQG)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR287UXS)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR269RPR)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR130TQM)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR088SOR)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR139PCE)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR266YIS)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Hi-C from A549 (ENCSR393LOP)

summary:
Hi-C on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR249JOH)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR979IOT)

summary:
HES2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR035OXA)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Hi-C from A549 (ENCSR244BBG)

summary:
Hi-C on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR090RGB)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR163EXK)

summary:
JunB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR233BJW)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR954HUB)

summary:
H3K4me1 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR952GOL)

summary:
NR3C1 (GR) ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR048CVK)

summary:
cJun ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR954SQX)

summary:
H3K9me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR964KSS)

summary:
HES2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR949IDI)

summary:
H3K4me1 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR948JXU)

summary:
BCL3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR936UEX)

summary:
H3K9me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR951SNW)

summary:
HES2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: polyA mRNA RNA-seq from A549 (ENCSR924BHF)

summary:
mRNA-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR944WVU)

summary:
H3K4me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR911KBJ)

summary:
HES2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR928FDN)

summary:
H3K4me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR173IEA)

summary:
CTCF ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR918VQU)

summary:
H3K4me2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR905REY)

summary:
H3K4me2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR909GTY)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR900RUE)

summary:
FOSL2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR901AAW)

summary:
H3K4me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR887SZF)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR872BBM)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR834LCU)

summary:
H3K4me2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR868MLT)

summary:
H3K4me1 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR919OXR)

summary:
NR3C1 (GR) ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR853DWE)

summary:
CEBPB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR792VMN)

summary:
EP300 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR873VJA)

summary:
H3K9me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR783SNV)

summary:
H3K27ac ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR841ASB)

summary:
EP300 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: DNase-seq from A549 (ENCSR837VHE)

summary:
DNase-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR775TAI)

summary:
H3K9me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR774KCU)

summary:
H3K4me2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR791BNU)

summary:
H3K9me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR770OTI)

summary:
EP300 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR796VBR)

summary:
HES2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR773NQB)

summary:
NR3C1 (GR) ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR752AQK)

summary:
CEBPB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR838ZAU)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR716XDB)

summary:
H3K27ac ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR775UFR)

summary:
FOSL2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR711MVL)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR730UDX)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR904OTM)

summary:
BCL3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR766NHB)

summary:
H3K4me2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR690HWX)

summary:
HES2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR726MAP)

summary:
H3K4me1 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR686HIU)

summary:
FOSL2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR692JHM)

summary:
H3K4me2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR720DXT)

summary:
NR3C1 (GR) ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR701TCU)

summary:
CEBPB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR690JTW)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR686BQM)

summary:
EP300 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR660RYY)

summary:
NR3C1 (GR) ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR677QYM)

summary:
H3K4me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: DNase-seq from A549 (ENCSR660OQE)

summary:
DNase-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR649JOE)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR686BIE)

summary:
HES2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR673OGC)

summary:
BCL3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR639KFO)

summary:
BCL3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR646OPC)

summary:
H3K4me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR636PIN)

summary:
H3K4me1 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: polyA mRNA RNA-seq from A549 (ENCSR656FIH)

summary:
mRNA-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR691GRA)

summary:
NR3C1 (GR) ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR614NPG)

summary:
H3K27ac ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: polyA mRNA RNA-seq from A549 (ENCSR632DQP)

summary:
mRNA-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR627RBH)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: polyA mRNA RNA-seq from A549 (ENCSR624RID)

summary:
mRNA-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR618MUP)

summary:
H3K4me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR646EFO)

summary:
HES2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR610RKF)

summary:
EP300 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR569IBY)

summary:
H3K27ac ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR611VYO)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: DNase-seq from A549 (ENCSR599WJC)

summary:
DNase-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR563GCV)

summary:
FOSL2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 10 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR686PFM)

summary:
NR3C1 (GR) ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR549SVK)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR555AYD)

summary:
BCL3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR606ZTC)

summary:
CEBPB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR548SPY)


title: ChIP-seq from A549 (ENCSR600LQZ)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR608QCS)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR544GUO)

summary:
BCL3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: polyA mRNA RNA-seq from A549 (ENCSR543QRU)

summary:
mRNA-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR561ZRE)

summary:
EP300 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR529YKU)

summary:
H3K4me1 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR537FVU)

summary:
H3K4me1 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: polyA mRNA RNA-seq from A549 (ENCSR546PPG)

summary:
mRNA-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: DNase-seq from A549 (ENCSR565WPR)

summary:
DNase-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR543ZVZ)

summary:
H3K27ac ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR524UOX)

summary:
H3K4me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR535HFQ)

summary:
FOSL2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: DNase-seq from A549 (ENCSR523FJT)

summary:
DNase-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR593RGY)

summary:
H3K4me1 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR593DGU)

summary:
FOSL2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR491TAD)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR487EUI)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR516IVY)

summary:
NR3C1 (GR) ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR555EAA)

summary:
H3K4me2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR467VXG)

summary:
EP300 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR462JVS)

summary:
H3K4me1 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR447ZMS)

summary:
CEBPB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR473CRE)

summary:
BCL3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR446SPT)

summary:
BCL3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR451MJX)

summary:
H3K9me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR425MXK)

summary:
HES2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR428DFL)

summary:
H3K4me2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR467GRT)


title: ChIP-seq from A549 (ENCSR424JOE)

summary:
NR3C1 (GR) ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR483JJT)

summary:
H3K4me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR435JKM)

summary:
H3K27ac ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 12 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: DNase-seq from A549 (ENCSR384KCZ)

summary:
DNase-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR385RUW)

summary:
NR3C1 (GR) ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR358ELZ)

summary:
EP300 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR474DCX)

summary:
CEBPB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR419TWL)

summary:
HES2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR410BCN)

summary:
H3K4me2 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: DNase-seq from A549 (ENCSR406EMB)

summary:
DNase-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR404OLV)

summary:
H3K4me1 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 8 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR375BUB)

summary:
CEBPB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 6 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: polyA mRNA RNA-seq from A549 (ENCSR385TFN)

summary:
mRNA-seq on A549 cell line treated with 100 nM dexamethasone for 7 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: polyA mRNA RNA-seq from A549 (ENCSR326PTW)

summary:
mRNA-seq on A549 cell line treated with 100 nM dexamethasone for 4 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR354ERB)

summary:
H3K9me3 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR325PXS)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 3 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: ChIP-seq from A549 (ENCSR344ERJ)

summary:
Control ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 2 hours.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf